United States· US:58411-673_47b9c2a8-0ac1-cc8b-e063-6394a90a2359
SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT
A medicinal product containing octinoxate; octocrylene; titanium dioxide, registered in United States by SHISEIDO AMERICAS CORPORATION.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE
- Manufacturer
- SHISEIDO AMERICAS CORPORATION
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1158411-673-20
- ndc1158411673201 TUBE in 1 CONTAINER (58411-673-20) / 30 mL in 1 TUBE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6e843e6-5a18-41d0-ab70-6382ae4e7829 GET /v1/drugs/e6e843e6-5a18-41d0-ab70-6382ae4e7829?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "2010; 900; 600",
"substance": "OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE",
"productndc": "58411-673",
"dosage_form": "EMULSION",
"dea_schedule": null,
"strength_unit": "mg/30mL; mg/30mL; mg/30mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate; octocrylene; titanium dioxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.